InMode Ltd.

InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has experienced significant stock fluctuations, with a recent close of $13.14. The stock's performance has lagged behind the S&P 500, showing a notable decline over the past year and longer periods, indicating challenges in the market.

InMode Ltd., a small-cap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company has reported negative results for five consecutive quarters, with a notable drop in net profit and operating cash flow.

InMode Ltd., a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently encountered a Death Cross, indicating a potential shift in market sentiment. The stock's technical indicators show a predominantly bearish outlook, with significant underperformance over the past year compared to the S&P 500.

InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has faced a challenging year with a significant decline in stock performance compared to the S&P 500. Current trading shows mixed technical indicators, reflecting both bearish and mildly bullish trends, amid a notable price range over the past year.

InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid market challenges. The stock is priced at $14.05, reflecting a significant decline over the past year. Technical indicators show mixed performance, highlighting volatility and the need for careful monitoring of its market position.

InMode Ltd., a small-cap biotechnology company, faced notable volatility, reaching an intraday low of USD 13.95 and declining 8.15% on February 24, 2026. The company reported a significant drop in net profit and operating cash flow, while its market capitalization stands at USD 1,239 million.

InMode Ltd., a small-cap company in the Pharmaceuticals & Biotechnology sector, experienced a notable decline in stock performance today. Despite this, the company has shown modest growth over the past month. Financial metrics indicate an attractive valuation, effective management, and a unique capital structure, presenting a complex landscape for stakeholders.

InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has seen its stock price rise slightly to $15.65. The company has experienced notable volatility over the past year, with a 52-week high of $19.85 and a low of $13.14, while its performance has lagged behind the S&P 500.

InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has seen fluctuations in its stock price, currently at $15.23. The company has faced challenges over the past year, with significant underperformance compared to the S&P 500, reflecting a competitive market environment.

InMode Ltd., a small-cap company in the Pharmaceuticals and Biotechnology sector, has seen a slight stock price increase to $15.01. Over the past year, it has struggled with a return of -13.83%, significantly underperforming the S&P 500. Technical indicators show mixed signals, reflecting caution in the short-term outlook.